FoxOs at the crossroads of cellular metabolism, differentiation, and transformation

Cell

Volumn 117, Issue 4, 2004, Pages 421-426

  Accili, Domenico ^a   Arden, Karen C ^b  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN D2; IMATINIB; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SIRTUIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR FOXO2; TRANSCRIPTION FACTOR FOXO4; UNCLASSIFIED DRUG;

ACETYLATION; ANGIOGENESIS; APOPTOSIS; CARCINOGENESIS; CELL DIFFERENTIATION; CELL METABOLISM; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSFORMATION; CHROMOSOME TRANSLOCATION; DIABETES MELLITUS; DRUG TARGETING; ENZYME INHIBITION; GENE EXPRESSION; GLUCONEOGENESIS; INSULIN RESISTANCE; MITOSIS INHIBITION; NEOPLASM; NONHUMAN; OVARY INSUFFICIENCY; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; RHABDOMYOSARCOMA; TRANSCRIPTION INITIATION;

EID: 2342496712     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(04)00452-0     Document Type: Review

References (37)

1. Anderson M.J., Shelton G.D., Cavenee W.K., Arden K.C. Embryonic expression of the tumor-associated PAX3-FKHR fusion protein interferes with the developmental functions of Pax3. Proc. Natl. Acad. Sci. USA. 98:2001;1589-1594
2. Birkenkamp K.U., Coffer P.J. Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Biochem. Soc. Trans. 31:2003;292-297
3. Bois P.R., Grosveld G.C. FKHR (FOXO1a) is required for myotube fusion of primary mouse myoblasts. EMBO J. 22:2003;1147-1157
4. Brunet A., Sweeney L.B., Sturgill J.F., Chua K.F., Greer P.L., Lin Y., Tran H., Ross S.E., Mostoslavsky R., Cohen H.Y., et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science. 303:2004;2011-2015
5. Burgering B.M., Kops G.J. Cell cycle and death control. long live Forkheads Trends Biochem. Sci. 27:2002;352-360
6. Calle E.E., Rodriguez C., Walker-Thurmond K., Thun M.J. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348:2003;1625-1638
7. Castrillon D.H., Miao L., Kollipara R., Horner J.W., DePinho R.A. Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science. 301:2003;215-218
8. Finch C.E., Ruvkun G. The genetics of aging. Annu. Rev. Genomics Hum. Genet. 2:2001;435-462
9. Fulco M., Schiltz R.L., Iezzi S., King M.T., Zhao P., Kashiwaya Y., Hoffman E., Veech R.L., Sartorelli V. Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol. Cell. 12:2003;51-62
10. Hosaka T., Biggs W.H. 3rd, Tieu D., Boyer A.D., Varki N.M., Cavenee W.K., Arden K.C. Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc. Natl. Acad. Sci. USA. 101:2004;2975-2980
11. Hribal M.L., Nakae J., Kitamura T., Shutter J.R., Accili D. Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factors. J. Cell Biol. 162:2003;535-541
12. Hu M.C.-T., Lee D.F., Xia W., Golfman L., Ou-Yang F., Hu L.S., Yang J.-Y., Zou Y., Bao S., Hanada N., et al. IkB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell. 117:2004;225-237
13. Junger M.A., Rintelen F., Stocker H., Wasserman J.D., Vegh M., Radimerski T., Greenberg M.E., Hafen E. The Drosophila Forkhead transcription factor FOXO mediates the reduction in cell number associated with reduced insulin signaling. J. Biol. 2:2003;20
14. Kau T.R., Schroeder F., Ramaswamy S., Wojciechowski C.L., Zhao J.J., Roberts T.M., Clardy J., Sellers W.R., Silver P.A. A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells. Cancer Cell. 4:2003;463-476
15. Kitamura T., Nakae J., Kitamura Y., Kido Y., Biggs W.H. 3rd, Wright C.V., White M.F., Arden K.C., Accili D. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J. Clin. Invest. 110:2002;1839-1847
16. Lagutina I., Conway S.J., Sublett J., Grosveld G.C. Pax3-FKHR knock-in mice show developmental aberrations but do not develop tumors. Mol. Cell. Biol. 22:2002;7204-7216
17. Lee S.S., Kennedy S., Tolonen A.C., Ruvkun G. DAF-16 target genes that control C. elegans life-span and metabolism. Science. 300:2003;644-647
18. Leenders H., Whiffield S., Benoist C., Mathis D. Role of the forkhead transcription family member, FKHR, in thymocyte differentiation. Eur. J. Immunol. 30:2000;2980-2990
19. Luo J., Nikolaev A.Y., Imai S., Chen D., Su F., Shiloh A., Guarente L., Gu W. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell. 107:2001;137-148
20. Modur V., Nagarajan R., Evers B.M., Milbrandt J. FOXO proteins regulate tumor necrosis factor-related apoptosis inducing ligand expression. Implications for PTEN mutation in prostate cancer. J. Biol. Chem. 277:2002;47928-47937
21. Motta M.C., Divecha N., Lemieux M., Kamel C., Chen D., Gu W., Bultsma Y., McBurney M., Guarente L. Mammalian SIRT1 represses forkhead transcription factors. Cell. 116:2004;551-563
22. Murphy C.T., McCarroll S.A., Bargmann C.I., Fraser A., Kamath R.S., Ahringer J., Li H., Kenyon C. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature. 424:2003;277-283
23. Nakae J., Biggs W.H., Kitamura T., Cavenee W.K., Wright C.V., Arden K.C., Accili D. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat. Genet. 32:2002;245-253
24. Nakae J., Kitamura T., Kitamura Y., Biggs W.H., Arden K.C., Accili D. The forkhead transcription factor foxo1 regulates adipocyte differentiation. Dev. Cell. 4:2003;119-129
25. North B.J., Marshall B.L., Borra M.T., Denu J.M., Verdin E. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol. Cell. 11:2003;437-444
26. Puig O., Marr M.T., Ruhf M.L., Tjian R. Control of cell number by Drosophila FOXO. downstream and feedback regulation of the insulin receptor pathway Genes Dev. 17:2003;2006-2020
27. Puigserver P., Rhee J., Donovan J., Walkey C.J., Yoon J.C., Oriente F., Kitamura Y., Altomonte J., Dong H., Accili D., Spiegelman B.M. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature. 423:2003;550-555
28. Relaix F., Polimeni M., Rocancourt D., Ponzetto C., Schafer B.W., Buckingham M. The transcriptional activator PAX3-FKHR rescues the defects of Pax3 mutant mice but induces a myogenic gain-of-function phenotype with ligand-independent activation of Met signaling in vivo. Genes Dev. 17:2003;2950-2965
29. Sandri M., Sandri C., Gilbert A., Skurk C., Calabria E., Picard A., Walsh K., Schiaffino S., Lecker S.H., Goldberg A.L. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell. 117:2004;399-412
30. Seoane J., Le H.-V., Shen L., Anderson S.A., Massagué J. Integration of Smad and Forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell. 117:2004;211-223
31. So C.W., Cleary M.L. Common mechanism for oncogenic activation of MLL by forkhead family proteins. Blood. 101:2003;633-639
32. Starai V.J., Celic I., Cole R.N., Boeke J.D., Escalante-Semerena J.C. Sir2-dependent activation of acetyl-CoA synthetase by deacetylation of active lysine. Science. 298:2002;2390-2392
33. Stitt, T.N., Drujan, D., Clarke, B.A., and Panaro, F.T.Y., Kline, W.O., Gonzales, M., Yancopoulos, G.D., and Glass, D.J. (2004). The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligasaes by inhibiting Foxo transcription factors. Mol. Cell 14, in press.
34. Vaziri H., Dessain S.K., Ng Eaton E., Imai S.I., Frye R.A., Pandita T.K., Guarente L., Weinberg R.A. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell. 107:2001;149-159
35. Xia S.J., Pressey J.G., Barr F.G. Molecular pathogenesis of rhabdomyosarcoma. Cancer Biol. Ther. 1:2002;97-104
36. Yin M.J., Yamamoto Y., Gaynor R.B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of 1(kappa)B kinase-beta. Nature. 396:1998;77-80
37. Yuan M., Konstantopoulos N., Lee J., Hansen L., Li Z.W., Karin M., Shoelson S.E. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science. 293:2001;1673-1677